股本结构
单位：万股
| 公告日期 | 2026-08-12 | 2026-05-13 | 2026-02-25 | 2026-02-25 | 2025-11-12 | 2025-08-13 |
|---|---|---|---|---|---|---|
| 证券总股本 | 2031.18 | 1917.41 | 1908.32 | 1820.40 | 1663.48 | 1565.41 |
| 普通股本 | 2031.18 | 1917.41 | 1908.32 | 1820.40 | 1663.48 | 1565.41 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2026-06-30 | 2026-03-31 | 2026-02-19 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2026-08-12 | 2031.18 | 未披露 | 定期报告 | 2026-06-30 |
| 2026-05-13 | 1917.41 | 未披露 | 定期报告 | 2026-03-31 |
| 2026-02-25 | 1908.32 | 未披露 | 定期报告 | 2026-02-19 |
| 2026-02-25 | 1820.40 | 未披露 |
更多>>
From December 31, 2024 to December 31, 2025
Issued abeyance shares
Exercise of pre-funded warrants
Issuance of ordinary shares, abeyance shares and warrants, net
Exercise of options
|
2025-12-31 |
| 2025-11-12 | 1663.48 | 未披露 | 定期报告 | 2025-09-30 |
| 2025-07-29 | 1589.72 | 未披露 | 定期报告 | 2025-07-27 |
| 2025-08-13 | 1565.41 | 未披露 | 定期报告 | 2025-06-30 |
| 2025-06-17 | 1781.74 | 未披露 |
更多>>
Ordinary shares offered 7,626,514 shares by the company.
|
2025-06-18 |
| 2025-02-26 | 1019.09 | 未披露 |
更多>>
From December 31, 2023 to December 31, 2024
Issuance of Ordinary shares, warrants and pre-funded warrants, net
|
2024-12-31 |
| 2024-12-26 | 1129.73 | 未披露 |
更多>>
On December 26, 2024 the investors purchase 4,493,830 of the Company’s ordinary shares
|
2024-12-26 |
| 2024-08-30 | 680.35 | 未披露 | 定期报告 | 2024-08-27 |
| 2024-02-01 | 479.73 | 未披露 | 定期报告 | 2024-01-31 |
| 2023-11-08 | 165.36 | 未披露 | 定期报告 | 2023-09-30 |
| 2023-09-20 | 163.50 | 未披露 |
更多>>
PolyPid Ltd. (the “Company”) hereby announces a reverse share split (the “Reverse Split”) of the Company’s issued and outstanding ordinary shares, no par value (“Ordinary Shares”), at the ratio of 1 for 30, such that each thirty (30) Ordinary Shares, shall be consolidated into one (1) Ordinary Share.
|
2023-09-21 |
| 2023-08-09 | 4904.87 | 未披露 | 定期报告 | 2023-06-30 |
| 2023-05-10 | 3869.42 | 未披露 | 定期报告 | 2023-03-31 |
| 2023-03-31 | 2183.52 | 未披露 | 定期报告 | 2023-03-30 |
| 2023-03-31 | 1985.18 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Issuance of Ordinary shares, net
Exercise of options
|
2022-12-31 |
| 2022-11-09 | 1965.56 | 未披露 | 定期报告 | 2022-09-30 |
| 2022-08-10 | 1955.12 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Issuance of shares, net
Exercise of options
|
2022-06-30 |
| 2022-05-11 | 1947.08 | 未披露 | 定期报告 | 2022-03-31 |
| 2021-08-11 | 1875.66 | 未披露 |
更多>>
From January 1, 2021 to June 30, 2021
Exercise of Warrants
Exercise of options
|
2021-06-30 |
| 2021-03-05 | 1874.51 | 未披露 | 定期报告 | 2021-03-01 |
| 2021-03-05 | 1849.47 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Issuance of Ordinary shares in connection with IPO, net of issuance costs of $6,243
Conversion of Convertible Preferred shares to Ordinary shares
Deemed dividend related to Series E-1 Preferred shares
Exercise of Warrants
Exercise of Options
|
2020-12-31 |
| 2020-11-12 | 1849.43 | 未披露 | 定期报告 | 2020-09-30 |
| 2020-06-29 | 1704.65 | 未披露 |
更多>>
1.Ordinary shares offered by the company 3,750,000 ordinary shares
2.Unless otherwise stated, the number of ordinary shares to be outstanding after this offering is based on 13,296,451 ordinary shares outstanding as of March 31, 2020
|
2020-06-26 |
From December 31, 2024 to December 31, 2025
Issued abeyance shares
Exercise of pre-funded warrants
Issuance of ordinary shares, abeyance shares and warrants, net
Exercise of options
Ordinary shares offered 7,626,514 shares by the company.
From December 31, 2023 to December 31, 2024
Issuance of Ordinary shares, warrants and pre-funded warrants, net
On December 26, 2024 the investors purchase 4,493,830 of the Company’s ordinary shares
PolyPid Ltd. (the “Company”) hereby announces a reverse share split (the “Reverse Split”) of the Company’s issued and outstanding ordinary shares, no par value (“Ordinary Shares”), at the ratio of 1 for 30, such that each thirty (30) Ordinary Shares, shall be consolidated into one (1) Ordinary Share.
From December 31, 2021 to December 31, 2022
Issuance of Ordinary shares, net
Exercise of options
From March 31, 2022 to June 30, 2022
Issuance of shares, net
Exercise of options
From January 1, 2021 to June 30, 2021
Exercise of Warrants
Exercise of options
From December 31, 2019 to December 31, 2020
Issuance of Ordinary shares in connection with IPO, net of issuance costs of $6,243
Conversion of Convertible Preferred shares to Ordinary shares
Deemed dividend related to Series E-1 Preferred shares
Exercise of Warrants
Exercise of Options
1.Ordinary shares offered by the company 3,750,000 ordinary shares
2.Unless otherwise stated, the number of ordinary shares to be outstanding after this offering is based on 13,296,451 ordinary shares outstanding as of March 31, 2020